Back to Blog
CGM & Devices October 14, 2026 SweetLife Team

Medtronic MiniMed 780G and Guardian 4: How SmartGuard Works and What the Trial Found

The MiniMed 780G is Medtronic's automated insulin delivery system: an insulin pump that reads a continuous glucose sensor and adjusts insulin on its own. The FDA approved it on April 21, 2023, for people with type 1 diabetes aged 7 and older. Here is what it actually does, what its pivotal trial found, and what changed with the Guardian 4 sensor.

SweetLife is an independent app and is not made by or affiliated with Medtronic. This article is general information, not a substitute for Medtronic's user guide or your care team, who set up and adjust the system.

What the 780G Does

In its automated mode, which Medtronic calls SmartGuard, the 780G does two things without being asked. Auto Basal adjusts your background insulin based on your sensor readings. Auto Correction delivers automatic correction doses when glucose runs high.

It is a hybrid system, not a fully closed loop: you still enter carbs and bolus for meals. The automation works in the space around them, adjusting background insulin and correcting when a meal dose did not quite cover things.

What the Pivotal Trial Found

The US pivotal trial, published in 2022, enrolled 157 people with type 1 diabetes: 39 adolescents aged 14 to 21 and 118 adults aged 22 to 75. After a run-in of about two weeks with partial or no automation, everyone used the full system — automatic basal and automatic corrections — for about 90 days. Compared with the run-in:

The benefits were similar in both age groups, and largest overnight, between midnight and 6 a.m.

The Settings That Moved the Numbers

Two settings made a measurable difference. Participants spent about 45 days each at a glucose target of 100 mg/dL and of 120 mg/dL. The 100 target produced more time in range, 75.4%. Time in range improved further when the active insulin time setting was 2 hours, without adding time below range.

Those are trial findings, not instructions. Your target and active insulin time are set with your care team, and the right values depend on you.

Guardian 4: No Routine Calibrations

The trials behind the 780G's approval used the earlier Guardian Sensor 3, which needed regular fingerstick calibrations. The Guardian 4 sensor does not: Medtronic says it does not require fingersticks for calibration. Two caveats are worth knowing:

Guardian 4 is worn for up to seven days, and Medtronic's user guide lists the back of the arm as its approved insertion site. The labeling also says sensor readings are not meant to be used directly for manual insulin decisions, so if you are dosing by hand and a reading does not match how you feel, confirm with a fingerstick first.

What Comes Next: Simplera Sync

In January 2024, Medtronic announced the world's first approval of the 780G paired with Simplera Sync, a disposable, all-in-one sensor. Availability depends on where you live, so check with Medtronic or your care team about what is offered to you.

Getting Your 780G Data Into SweetLife

Your 780G's data goes to Medtronic CareLink, and SweetLife can sync from CareLink so your readings flow in automatically in the background, alongside your meals, logs and insights. The CareLink connection needs you to sign in again about every two months. Our step-by-step guide covers syncing your Medtronic pump with SweetLife, and our comparison of CareLink and Dexcom Clarity looks at what each one shows.

The Short Version

The MiniMed 780G automates basal insulin and correction doses while you still bolus for meals. In its pivotal trial, time in range rose to 74.5% and A1C fell to 7.0%, with less time low and no severe lows or DKA; the 100 mg/dL target and a 2-hour active insulin time did better still. Guardian 4 removes routine calibrations, though the system may still ask for an occasional fingerstick. Your care team sets the numbers; the system does the minute-to-minute work.

Sources

Medical Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider with any questions about a medical condition or changes to your diabetes management plan, including medication, insulin dosing, and pre-bolusing timing. SweetLife is a tracking and logging tool, not a medical device, and does not provide medical advice.

Back to Blog